{"id":61044,"date":"2025-04-04T19:02:39","date_gmt":"2025-04-04T17:02:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/"},"modified":"2025-04-04T19:02:39","modified_gmt":"2025-04-04T17:02:39","slug":"raythera-raises-110-million-in-series-a-financing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/","title":{"rendered":"RayThera Raises $110 Million in Series A Financing"},"content":{"rendered":"
\n

\nFinancing will support advancement of preclinical immunology pipeline<\/i><\/b>\n<\/p>\n

SAN DIEGO–(BUSINESS WIRE)–RayThera, Inc., a recently founded biotechnology company currently focused on discovering and developing small molecule therapies in immunology, announced today that it has completed its Series A financing, with a total of $110M raised. The financing was co-led by Foresite Capital and OrbiMed Advisors, with participation from TTM Capital. Proceeds from the financing will be used to advance RayThera\u2019s lead drug candidates through Phase 1 clinical studies.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nCo-founded by Qing Dong, Ph.D., and Gene Hung, M.D., the company is led by a team of highly skilled drug hunters and executives with an extraordinary track record in the biotech and pharma industries.\n<\/p>\n

\n\u201cWe are grateful for the strong support from our investors, the same syndicate who funded our previous venture, XinThera,\u201d said Qing Dong, co-founder, chairman and CEO of RayThera, \u201cTheir continued backing is instrumental as we advance our pipeline.\u201d\n<\/p>\n

\n\u201cI\u2019ve been impressed with the progress that the RayThera team has made in such a short time,\u201d commented Michael Rome, Ph.D., Foresite Capital\u2019s Partner and member of RayThera\u2019s board of directors. \u201cOur ongoing collaboration with this skilled team exemplifies our commitment to back repeat entrepreneurs who have strong track records partnering with us.\u201d\n<\/p>\n

\n\u201cWe are proud to continue our partnership with this incredibly talented team as they work to develop first-in-class and best-in-class therapies in areas of high unmet need,\u201d remarked Carl Gordon, Ph.D., CFA, General Partner at OrbiMed and member of RayThera\u2019s board of directors.\n<\/p>\n

\nAbout RayThera, Inc.<\/strong>\n<\/p>\n

\nRayThera, Inc. is a small molecule drug discovery company focused on building an immunology pipeline. RayThera is based in San Diego, CA.\n<\/p>\n

\nFor more information, visit www.raythera.com<\/a>.\n<\/p>\n

\nAbout Foresite Capital<\/strong>\n<\/p>\n

\nForesite Capital is a multi-stage healthcare and life sciences investment firm with more than $3.5 billion in assets under management. The firm aims to address areas of unmet medical need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Founded in 2011, Foresite Capital is based in the San Francisco Bay Area, Los Angeles, and New York City. For more information, please visit www.foresitecapital.com<\/a>.\n<\/p>\n

\nAbout OrbiMed Advisors<\/strong>\n<\/p>\n

\nOrbiMed is a global investment firm that invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMary Gieson
\n
VP Corporate Operations
\n
RayThera, Inc.
\n
mgieson@raythera.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Financing will support advancement of preclinical immunology pipeline SAN DIEGO–(BUSINESS WIRE)–RayThera, Inc., a recently founded biotechnology company currently focused on discovering and developing small molecule therapies in immunology, announced today that it has completed its Series A financing, with a total of $110M raised. The financing was co-led by Foresite Capital and OrbiMed Advisors, with … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61044","6":"format-standard","7":"category-industry"},"yoast_head":"\nRayThera Raises $110 Million in Series A Financing - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RayThera Raises $110 Million in Series A Financing - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Financing will support advancement of preclinical immunology pipeline SAN DIEGO–(BUSINESS WIRE)–RayThera, Inc., a recently founded biotechnology company currently focused on discovering and developing small molecule therapies in immunology, announced today that it has completed its Series A financing, with a total of $110M raised. The financing was co-led by Foresite Capital and OrbiMed Advisors, with ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-04T17:02:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250404667548\/en\/2428664\/22\/RayThera_Logo_-_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RayThera Raises $110 Million in Series A Financing\",\"datePublished\":\"2025-04-04T17:02:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/\"},\"wordCount\":415,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250404667548\\\/en\\\/2428664\\\/22\\\/RayThera_Logo_-_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/\",\"name\":\"RayThera Raises $110 Million in Series A Financing - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250404667548\\\/en\\\/2428664\\\/22\\\/RayThera_Logo_-_RGB.jpg\",\"datePublished\":\"2025-04-04T17:02:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250404667548\\\/en\\\/2428664\\\/22\\\/RayThera_Logo_-_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250404667548\\\/en\\\/2428664\\\/22\\\/RayThera_Logo_-_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/raythera-raises-110-million-in-series-a-financing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RayThera Raises $110 Million in Series A Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RayThera Raises $110 Million in Series A Financing - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/","og_locale":"en_US","og_type":"article","og_title":"RayThera Raises $110 Million in Series A Financing - Pharma Trend","og_description":"Financing will support advancement of preclinical immunology pipeline SAN DIEGO–(BUSINESS WIRE)–RayThera, Inc., a recently founded biotechnology company currently focused on discovering and developing small molecule therapies in immunology, announced today that it has completed its Series A financing, with a total of $110M raised. The financing was co-led by Foresite Capital and OrbiMed Advisors, with ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/","og_site_name":"Pharma Trend","article_published_time":"2025-04-04T17:02:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250404667548\/en\/2428664\/22\/RayThera_Logo_-_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RayThera Raises $110 Million in Series A Financing","datePublished":"2025-04-04T17:02:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/"},"wordCount":415,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250404667548\/en\/2428664\/22\/RayThera_Logo_-_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/","url":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/","name":"RayThera Raises $110 Million in Series A Financing - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250404667548\/en\/2428664\/22\/RayThera_Logo_-_RGB.jpg","datePublished":"2025-04-04T17:02:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250404667548\/en\/2428664\/22\/RayThera_Logo_-_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250404667548\/en\/2428664\/22\/RayThera_Logo_-_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/raythera-raises-110-million-in-series-a-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RayThera Raises $110 Million in Series A Financing"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61044"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61044\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}